Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience One of the most common questions families ask after a Stargardt’s disease diagnosis is simply what to expect going forward – how quickly vision may change, and what that means […]

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience A Stargardt’s disease diagnosis in one family member often raises immediate questions for others – about their own risk, about future children, and about what steps actually make sense to

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. B. N. Singh (General Physician, MBBS MS General Surgery, 30+ years) Gene therapy research for Stargardt’s disease has continued to develop as an active area of study, and patients and families understandably want a clear, honest sense of where things currently

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Patients newly diagnosed with Stargardt’s disease often leave their doctor’s office with a list of unfamiliar test names – fundus autofluorescence, OCT, ERG – without a clear sense of what

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. B. N. Singh (General Physician, MBBS MS General Surgery, 30+ years) Stargardt’s disease and age-related macular degeneration (AMD) are sometimes confused with one another, partly because both affect the macula and cause central vision loss. But they are fundamentally different conditions

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Stargardt’s disease is the most common inherited macular degeneration affecting children and young adults, yet it’s a condition many families have never heard of until diagnosis. Here’s a clear explanation

Introduction Researchers worldwide are investigating regenerative medicine approaches, including stem cell-based therapies, to address retinal degeneration associated with Stargardt’s disease. While promising, these treatments remain an active area of clinical research. Understanding Retinal Damage Role of the macula Photoreceptor cells Retinal pigment epithelium (RPE) Why central vision is affected What Are Stem Cells? Explain: Adult

Introduction Stargardt’s disease is one of the most common inherited macular disorders affecting children, teenagers, and young adults. It gradually damages the central retina (macula), leading to progressive vision loss while peripheral vision often remains intact. Although there is currently no definitive cure, early diagnosis, low-vision support, and ongoing advances in stem cell research are

Central Areolar Choroidal Dystrophy (CACD) Central Areolar Choroidal Dystrophy (CACD) is a rare inherited macular disease that gradually damages the central part of the retina responsible for detailed vision. As the condition progresses, the retinal pigment epithelium (RPE), photoreceptors, and choriocapillaris in the macula slowly deteriorate, leading to progressive central vision loss while peripheral vision

Hereditary Macular Dystrophy (HMD) is a group of inherited eye disorders that affect the macula, the central part of the retina responsible for sharp and detailed vision. These conditions are caused by genetic mutations and can gradually reduce a person’s ability to read, recognize faces, drive, or perform tasks requiring clear central vision. While peripheral